DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Janni W, Wiedswang G, Fehm T. et al.
Persistence of disseminated tumor cells (DTC) in bone marrow (BM) during follow-up predicts increased risk for relapse up-date of the pooled European data.
Breast Cancer Res Treat. 2006;
100 (Suppl 1) A18.
We do not assume any responsibility for the contents of the web pages of other providers.